WNT Signalling Promotes NF-κB Activation and Drug Resistance in KRAS-Mutant Colorectal Cancer
B. Cong, E. Stamou, K. Pennel, M. McKenzie, A. Matly, J. Edwards, R. Cagan
This study shows that WNT signaling enhances NF-κB activation and drug resistance in KRAS-mutant colorectal cancer, suggesting a therapeutic strategy targeting WNT and MEK pathways.
bioRxiv · Dec 21, 2023Cancer Biology